Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Penyan Kangning Capsules
- Development stage
- Phase 2
- Lead developer
- Xi'an Shangyikang Pharmaceutical Research Institute
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Penyan Kangning Capsules is a traditional Chinese medicine (TCM) capsule formulation being developed by Xi'an Shangyikang Pharmaceutical Research Institute and Huachuang Synthetic Pharmaceutical. It is designed to clear damp-heat, resolve blood stasis, and dissipate nodules, and is primarily indicated for the treatment of chronic pelvic pain caused by the sequelae of pelvic inflammatory disease (specifically classified as the damp-heat and blood stasis TCM syndrome). The drug is currently in Phase II clinical development in China.
- Other names
- 盆炎康宁胶囊
Beyond the preview
Go deeper on Penyan Kangning Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Penyan Kangning Capsules.